Evidence-based recommendations on maribavir (Livtencity) for cytomegalovirus infection in adults after transplant.
Commercial arrangement
There is a simple discount patient access scheme for maribavir. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisat...
The Practice Guidelines Committee of the American Society of Transplantation and Cellular Therapy (ASTCT) partnered with its Transplant Infectious Disease Special Interest Group (TID-SIG) to update its 2009 compendium-style infectious disease guidelines for hematopoietic cell transplantation (HCT). A new...
The Practice Guidelines Committee of the American Society for Transplantation and Cellular Therapy partnered with its Transplant Infectious Disease Special Interest Group to update its 2009 compendium-style infectious diseases guidelines for the care of hematopoietic cell transplant (HCT) recipients. A n...
The purpose of this guideline is to maximise the safety of patients who need haemopoietic stem cell transplantation and make the best use of NHS resources, while protecting staff from infection. It will also enable services to match the capacity for transplantation to patient needs if services become lim...
To develop an evidence-based clinical practice guideline for the prevention of oral mucositis in children (0-18 years) receiving treatment for cancer or undergoing haematopoietic stem cell transplantation (HSCT).
The Mucositis Prevention Guideline Development Group was interdisciplinary and included in...
Sarmati, L;
Andreoni, M;
Antonelli, G;
Arcese, W;
Bruno, R;
Coppola, N;
Gaeta, G. B;
Galli, M;
Girmenia, C;
Mikulska, M;
Pane, F;
Perno, C. F;
Picardi, M;
Puoti, M;
Rambaldi, A;
Svicher, V;
Taliani, G;
Gentile, G.
SCOPE: Hepatitis B virus (HBV) infection reactivation is associated with high morbidity and mortality in patients with haematologic malignancy and/or haematopoietic stem cell transplantation (HSCT). However, information on this issue is limited. The scope of this position paper is to provide recommendati...
A review of the British Society for Histocompatibility and Immunogenetics (BSHI) "Guideline for selection and HLA matching of related, adult unrelated donors and umbilical cord units for haematopoietic progenitor cell transplantation" was undertaken by a BSHI appointed writing committee. Literature searc...
Lehrnbecher, T;
Phillips, R;
Alexander, S;
Alvaro, F;
Carlesse, F;
Fisher, B;
Hakim, H;
Santolaya, M;
Castagnola, E;
Davis, B. L;
Dupuis, L. L;
Gibson, F;
Groll, A. H;
Gaur, A;
Gupta, A;
Kebudi, R;
Petrilli, S. L;
Steinbach, W. J;
Villarroel, M;
Zaoutis, T Sung.
To develop an evidence-based guideline for the empiric management of pediatric fever and neutropenia (FN). The International Pediatric Fever and Neutropenia Guideline Panel is a multidisciplinary and multinational group composed of experts in pediatric oncology and infectious disease as well as a patient...
Elaborar una guía de practica clínica (GPC) para orientar a los profesionales sanitarios en la toma de decisiones y disminuir la variabilidad en la atención a las personas con Esclerosis múltiple (EM). Proporcionar información útil para los pacientes, familiares y cuidadores que les permita conocer...
Esclerose Múltipla/terapia,
Esclerose Múltipla/diagnóstico por imagem,
Esclerose Múltipla/tratamento farmacológico,
Espectroscopia de Ressonância Magnética/métodos,
Interferon beta/uso terapêutico,
Acetato de Glatiramer/uso terapêutico,
Azatioprina/uso terapêutico,
Natalizumab/uso terapêutico,
Cloridrato de Fingolimode/uso terapêutico,
Mitoxantrona/uso terapêutico,
Metotrexato/uso terapêutico,
Ciclofosfamida/uso terapêutico,
Transplante de Células-Tronco Hematopoéticas,
Corticosteroides/uso terapêutico
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Anticorpos Monoclonais,
Anticorpos,
Anticorpos Monoclonais Murinos/uso terapêutico,
Antineoplásicos,
Esquema de Medicação,
Transplante de Células-Tronco Hematopoéticas,
Linfoma Folicular/patologia,
Linfoma/terapia,
Estadiamento de Neoplasias,
Rituximab,
Fatores de Tempo
